Detalhe da pesquisa
1.
Meningococcal ACWYX Conjugate Vaccine in 2-to-29-Year-Olds in Mali and Gambia.
N Engl J Med
; 388(21): 1942-1955, 2023 May 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-37224196
2.
Immunogenicity and safety of a 10-valent pneumococcal conjugate vaccine administered as a 2 + 1 schedule to healthy infants in The Gambia: a single-centre, double-blind, active-controlled, randomised, phase 3 trial.
Lancet Infect Dis
; 23(5): 609-620, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36638819
3.
Development strategy and lessons learned for a 10-valent pneumococcal conjugate vaccine (PNEUMOSIL®).
Hum Vaccin Immunother
; 17(8): 2670-2677, 2021 08 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33625961
4.
Immunogenicity and safety of a novel ten-valent pneumococcal conjugate vaccine in healthy infants in The Gambia: a phase 3, randomised, double-blind, non-inferiority trial.
Lancet Infect Dis
; 21(6): 834-846, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33516293
5.
Safety and immunogenicity of a novel 10-valent pneumococcal conjugate vaccine candidate in adults, toddlers, and infants in The Gambia-Results of a phase 1/2 randomized, double-blinded, controlled trial.
Vaccine
; 38(2): 399-410, 2020 01 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31843266